According to EvoHealth's Sharon Musgrave, who led the report's development, “With the results observed to date in clinical trials of CAR T-cell therapies and more than a thousand ongoing trials investigating CAR T-cell therapy, the time to prepare the clinical workforce and establish nationwide funding is now.” …
New report calls for the development and adoption of a national plan for CAR T-cell therapy
May 9, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
OncoSil Medical completes recruitment in TRIPP-FFX clinical trial
July 23, 2025 - - Australian Biotech -
Nyrada advances Xolatryp towards Phase 2a trial in cardioprotection
July 23, 2025 - - Australian Biotech -
Amplia Therapeutics announces $25 million placement and launches share purchase plan
July 23, 2025 - - Australian Biotech -
Percheron Therapeutics announces publication of new preclinical HMBD-002 data
July 23, 2025 - - Australian Biotech -
US leads the way on cell and gene therapy with new rapid access program
July 23, 2025 - - Latest News -
Neuraxpharm continues international expansion with launch of Australian affiliate
July 23, 2025 - - Latest News -
Companies secure certification as 'Great Places to Work'
July 23, 2025 - - Latest News